Abstract
According to the Centers for Disease Control and Prevention in the USA, reported that the risk of infection with COVID-19 increases with age, especially in older adults, and those who suffered from other immune diseases or continuously taking medications. Some elderlies are immunosenescence due to the decline in an immune system’s functionality with age, thus, the COVID-19 vaccine may not be effective for them and it is big trouble. How does the COVID-19 vaccine induce robust immune responses in the elderly? In general, the number of naive T cells decreases while age increases. This makes the B cells lose their function and less attachment on the antibodies surface lead unable to defend and target the virus for destruction causing it cannot engulf the virus and nor cause inflammation to remove the infected cells. Therefore, it is not easy to develop a suitable COVID-19 for the elderly. Pawelec et al. indicated that it must have a biomarker in the elderly COVID-19 vaccine. There is an investigation of the Yellow Fever vaccination. (To be continued)...
Highlights
Control and Prevention in the USA, the risk of infection with COVID-19 increases with age, especially in older adults, and those who suffered from other immune diseases or continuously taking medications
Pawelec et al indicated that it must have a biomarker in the elderly, the COVID-19 vaccine
Besides strengthening the immune response, COVID-19 vaccine could block the interactions between viral proteins and host cell molecules acting as receptors
Summary
Letter history: Received 18 October 2020 Received in revised form 13 November 2020 Accepted 16 November 2020 Control and Prevention in the USA, the risk of infection with COVID-19 increases with age, especially in older adults, and those who suffered from other immune diseases or continuously taking medications. Some elderly are immunosenescence due to the decline in the immune system’s functionality with age, the COVID-19 vaccine may not be effective for them which is a big trouble [1,2].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
